I'm LongbridgeAI, I can summarize articles.RBC Capital analyst Trung Huynh maintained a Buy rating on AstraZeneca today and set a price target of £145.00. According to TipRanks, Huynh is a 5-star analyst with an average return of 22.7% and a 75.69% success rate. Huynh covers the Healthcare sector, focusing on stocks such as Bristol-Myers Squibb, Merck & Company, and Pfizer. In addition to RBC Capital, AstraZeneca also received a Buy from Barclays’s James Gordon CFA in a report issued yesterday. However, today, Deutsche Bank maintained a Sell rating on AstraZeneca (LSE: AZN).
RBC Capital analyst Trung Huynh maintained a Buy rating on AstraZeneca today and set a price target of £145.00.
According to TipRanks, Huynh is a 5-star analyst with an average return of 22.7% and a 75.69% success rate. Huynh covers the Healthcare sector, focusing on stocks such as Bristol-Myers Squibb, Merck & Company, and Pfizer.
In addition to RBC Capital, AstraZeneca also received a Buy from Barclays’s James Gordon CFA in a report issued yesterday. However, today, Deutsche Bank maintained a Sell rating on AstraZeneca (LSE: AZN).